Search

everythinglearnresearchcommunity

for

Search:↓

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Netherton syndrome can cause severe dehydration, infections, and growth issues in infants.

Certain gene mutations can weaken the skin barrier and, when combined with environmental factors, lead to eczema and severe itching.

Understanding drug effects and careful monitoring are crucial for safe and effective dermatology treatments.

Mf-rich hair degrades more than Ma-rich hair, especially with Proteinase K.

Platelet-rich plasma shows promise for skin and hair treatments but needs more research and standardization.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Stress can stop hair growth in mice, and treatments can reverse this effect.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Cystatin M/E strongly inhibits cathepsin V and cathepsin L, important for skin formation.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

TPA is about 50 times more effective at promoting tumors than MZ.

A20 protein is crucial for normal skin and hair development.

ZDHHC13 is important for normal liver function and metabolism, affecting mitochondrial activity.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

Wnt signaling may be linked to heart diseases in aging and could be a target for future treatments.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Keratins are important for skin cell health and their problems can cause diseases.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Low-potency steroids can cause serious side effects in people with skin conditions like Netherton syndrome.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

AGA linked to worse COVID-19 outcomes in men.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Genetic marker rs12558842 strongly linked to male hair loss.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.